hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06341036, orgStudyIdInfo id: Thrombocytosis in Children, briefTitle: Aetiology And Outcome Of Children With Thrombocytosis Admitted to Assiut University Children Hospital, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-07-15, primaryCompletionDateStruct date: 2025-03-03, completionDateStruct date: 2026-03-03, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: The primary Aim :to determine the etiology of thrombocytosis in children and frequency, outcome of thrombocytosis in Children., conditionsModule conditions: Thrombocytosis in Children, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 42, type: ESTIMATED, outcomesModule primaryOutcomes measure: Aetiology And Outcome Of children with Thrombocytosis admitted to Assiut University children hospital, eligibilityModule sex: ALL, minimumAge: 1 Month, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06341010, orgStudyIdInfo id: The Role of Angiojet Rheolytic, briefTitle: The Role of Angiojet Rheolytic Thrombectomy in The Management of Iliofemoral Deep Venous Thrombosis, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2026-01-01, completionDateStruct date: 2026-09-01, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Abdelrahman Ibrahim Sayed Mohamed Abdalla, class: OTHER, descriptionModule briefSummary: The aim of this study is to evaluate the efficacy and safety of rheolytic thrombectomy in restoring venous patency DVT, periprocedural complications and development of PTS after tratment of iliofemoral DVT., conditionsModule conditions: Iliofemoral Deep Vein Thrombosis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 25, type: ESTIMATED, armsInterventionsModule interventions name: Angiojet Rheolytic Thrombectomy in The Management of Iliofemoral Deep Venous Thrombosis, outcomesModule primaryOutcomes measure: Technical success, secondaryOutcomes measure: Incidence of PTS, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06340997, orgStudyIdInfo id: Mitral Stenosis, briefTitle: Impact of Percutaneous Transvenous Mitral Commissurotomy on The Left Atrial Appendage Function in Patients With Mitral Stenosis., statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-07-01, primaryCompletionDateStruct date: 2026-10-01, completionDateStruct date: 2027-08-01, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: • Evaluation of the effect of PTMC on LAA function by TEE at least one month after the procedure and its effectiveness in prevention of thrombi formation and cerebrovascular complications., conditionsModule conditions: Mitral Stenosis, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 25, type: ESTIMATED, armsInterventionsModule interventions name: Transesophageal echocardiography, outcomesModule primaryOutcomes measure: Impact of Percutaneous Transvenous Mitral Commissurotomy on The Left Atrial Appendage Function in Patients with Mitral Stenosis., secondaryOutcomes measure: Prevention of left atrial appendage thrombus., eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06340984, orgStudyIdInfo id: sICAM-1 in acne vulgaris, briefTitle: Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06, primaryCompletionDateStruct date: 2024-11, completionDateStruct date: 2025-02, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-03, sponsorCollaboratorsModule leadSponsor name: South Valley University, class: OTHER, descriptionModule briefSummary: The aim of this study is to:1. Evaluation of serum soluble intercellular adhesion molecule-1 (sICAM-1) level in acne vulgaris and compare it to control group2. Evaluate its role in acne pathogenesis and its correlation with acne vulgaris severity3. Evaluate the effect of Montelukast on serum (sICAM-1) level in acne vulgaris, conditionsModule conditions: Acne Vulgaris, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Montelukast 10 Mg Oral Tablet, outcomesModule primaryOutcomes measure: Evaluation of serum soluble intercellular adhesion molecule-1 (sICAM-1) level in acne vulgaris (moderate -severe ), primaryOutcomes measure: Montelukast in treatment of acne vulgaris patients, eligibilityModule sex: ALL, minimumAge: 15 Years, maximumAge: 35 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06340971, orgStudyIdInfo id: 331247, briefTitle: Air Pollution and Pregnancy, acronym: PTB, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-09-01, primaryCompletionDateStruct date: 2029-08-31, completionDateStruct date: 2029-08-31, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Queen Mary University of London, class: OTHER, collaborators name: University College London Hospitals, descriptionModule briefSummary: We are an inter-disciplinary team of UK scientists with expertise in obstetrics, women's and child health, epidemiology, climate science, inflammation, computational modelling, machine learning and artificial intelligence. Together we have a long history with existing strengths underlying preterm birth research that crosses multiple disciplines and an excellent track record of publications and awards leading research in preterm birth.We aim to develop and validate a deep learning model to predict the risk of preterm birth and other adverse pregnancy outcomes using data from EPIC electronic health records at University College London Hospital Trust (UCLH) for a cohort of 18000 patients. We will obtain corresponding data on exposure to ambient pollution using non-identifiers for postcode (area) and date of delivery (month). The model will review the temporal sequence of events within a patient's medical history and current pregnancy, identifying significant interactions and will predict the risk of preterm birth. It will also determine the threshold and gestation at which pollution exposure has the greatest impact., conditionsModule conditions: Premature Birth, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: OTHER, enrollmentInfo count: 200000, type: ESTIMATED, armsInterventionsModule interventions name: Policy, outcomesModule primaryOutcomes measure: Machine learning model to predict the risk of preterm birth and adverse birth outcomes, secondaryOutcomes measure: Machine learning model to predict how air quality increases the risk of preterm birth and adverse birth outcomes, eligibilityModule sex: FEMALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Tina Chowdhury, status: RECRUITING, city: London, zip: E14NS, country: United Kingdom, contacts name: Tina Chowdhury, role: CONTACT, phone: 0207882, phoneExt: 7560, email: t.t.chowdhury@qmul.ac.uk, contacts name: Rhona Atkins, role: CONTACT, phone: 0207882, phoneExt: 7272, email: rhona.atkin@nhs.net, geoPoint lat: 51.50853, lon: -0.12574, locations facility: Anna David, status: RECRUITING, city: London, zip: NW1 2PG, country: United Kingdom, contacts name: Yaa Acheampong, role: CONTACT, phone: 020 3447, phoneExt: 6164, email: y.acheampong@nhs.net, contacts name: Anna David, role: CONTACT, phone: 0203 447, phoneExt: 9400, email: a.david@nhs.net, geoPoint lat: 51.50853, lon: -0.12574, hasResults: False
protocolSection identificationModule nctId: NCT06340958, orgStudyIdInfo id: CLE100-MDD-202, briefTitle: A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder, acronym: SOLEO, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-18, primaryCompletionDateStruct date: 2025-07-11, completionDateStruct date: 2026-01-10, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Clexio Biosciences Ltd., class: INDUSTRY, descriptionModule briefSummary: The study is a Phase 2, double-blind, randomized, placebo-controlled study in Major Depressive Disorder (MDD) participants with an inadequate response to standard antidepressants The objective of the study is to assess CLE-100 (oral esketamine) for the treatment of MDD in participants currently treated with an oral antidepressant medication and who have an inadequate response to at least 2 antidepressants., conditionsModule conditions: Adjunctive Treatment of Major Depressive Disorder (MDD), designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 90, type: ESTIMATED, armsInterventionsModule interventions name: CLE-100, interventions name: Placebo, outcomesModule primaryOutcomes measure: Change from Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) score, secondaryOutcomes measure: Change from Baseline in the Clinical Global Impression - Severity (CGI-S), secondaryOutcomes measure: Change from Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) score, secondaryOutcomes measure: Safety Outcomes: Assessment of the safety and tolerability of CLE-100 compared to placebo, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Clinical Site 105, status: RECRUITING, city: Lauderhill, state: Florida, zip: 33319, country: United States, geoPoint lat: 26.14036, lon: -80.21338, locations facility: Clinical SIte 112, status: RECRUITING, city: Miami Lakes, state: Florida, zip: 33016, country: United States, geoPoint lat: 25.90871, lon: -80.30866, locations facility: Clinical Site 118, status: RECRUITING, city: Atlanta, state: Georgia, zip: 30030, country: United States, geoPoint lat: 33.749, lon: -84.38798, locations facility: Clinical Site 128, status: RECRUITING, city: Marlton, state: New Jersey, zip: 08054, country: United States, geoPoint lat: 39.89122, lon: -74.92183, locations facility: Clinical Site 101, status: RECRUITING, city: Toms River, state: New Jersey, zip: 08755, country: United States, geoPoint lat: 39.95373, lon: -74.19792, hasResults: False
protocolSection identificationModule nctId: NCT06340945, orgStudyIdInfo id: S2023-761-01, briefTitle: The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2027-12-31, completionDateStruct date: 2029-12-31, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Chinese PLA General Hospital, class: OTHER, descriptionModule briefSummary: 1. To evaluate the clinical outcomes of ultrasound-guided thermal ablationfor the treatment of benign thyroid nodules;2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of benign thyroid nodules, conditionsModule conditions: Thyroid Nodules, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SEQUENTIAL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 1500, type: ESTIMATED, armsInterventionsModule interventions name: ultrasound-guided thermal ablation, outcomesModule primaryOutcomes measure: volume reduction rate, primaryOutcomes measure: rate of nodule regrowth, secondaryOutcomes measure: rate of complications, secondaryOutcomes measure: cosmetic score, secondaryOutcomes measure: symptom score, secondaryOutcomes measure: vital volume, secondaryOutcomes measure: total volume, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06340919, orgStudyIdInfo id: 1406014978-241, briefTitle: Hearing Aid Algorithms for Sudden Sounds, statusModule overallStatus: ENROLLING_BY_INVITATION, startDateStruct date: 2024-02-21, primaryCompletionDateStruct date: 2024-09-30, completionDateStruct date: 2025-05-31, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Purdue University, class: OTHER, collaborators name: Oticon, descriptionModule briefSummary: This study explores the impact of hearing aid settings for managing sudden sounds on speech comprehension and recall in individuals with hearing loss. Participants will undergo a comprehensive audiological evaluation, case history, and cognitive assessments. Subsequently, they will participate in listening experiments designed to measure sentence recognition, storage, and retrieval under various sudden sound reduction conditions recorded through a hearing aid. The experiment will be complemented by subjective preference ratings to identify participant comfort and listening clarity associated with different sudden sound reduction settings., conditionsModule conditions: Hearing Loss, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Sudden Sound Reduction Setting, outcomesModule primaryOutcomes measure: Speech recognition, primaryOutcomes measure: Recall, primaryOutcomes measure: Preference, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 79 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Purdue University, city: West Lafayette, state: Indiana, zip: 47907, country: United States, geoPoint lat: 40.42587, lon: -86.90807, hasResults: False
protocolSection identificationModule nctId: NCT06340880, orgStudyIdInfo id: SAPB, briefTitle: Serratus Anterior Plane Block, Ultrasound vs Anatomical Landmark Guided., statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-05, completionDateStruct date: 2024-05, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Menoufia University, class: OTHER, descriptionModule briefSummary: This prospective, double-blinded randomized controlled trial aims to compare the efficacy of the serratus anterior plane block (SAPB) ultrasound guided versus anatomical landmark guided for gynecomastia surgery. And to detect if the anatomical landmark technique is inferior or not to the ultrasound guided technique. We hypothesize that anatomical landmark guided SAPB is not inferior to ultrasound guided SAPB., conditionsModule conditions: Serratus Anterior Plane Block, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Serratus anterior plane block, outcomesModule primaryOutcomes measure: visual numerical rating score (NRS), secondaryOutcomes measure: first call of analgesia, secondaryOutcomes measure: incidence of complications, secondaryOutcomes measure: patient satisfaction, eligibilityModule sex: MALE, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Menoufia University Hospitals, status: RECRUITING, city: Shibīn Al Kawm, state: Menoufia, country: Egypt, contacts name: Menoufia U Hospitals, role: CONTACT, phone: +20482228303, email: info@menofia.edu.eg, geoPoint lat: 30.55258, lon: 31.00904, hasResults: False
protocolSection identificationModule nctId: NCT06340867, orgStudyIdInfo id: 30723, briefTitle: Intraoral Scanner With and Without Orthodontic Brackets, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2023-09-01, primaryCompletionDateStruct date: 2024-03-24, completionDateStruct date: 2024-04-01, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: this study aim to evaluate the effect of two different intraoral scanners on the scanning Quality and Time in Patients With/Without Orthodontic Brackets, conditionsModule conditions: Intra-oral Scanner, conditions: Adolescent Behavior, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 10, type: ACTUAL, armsInterventionsModule interventions name: CEREC primescan intra-oral scanner, outcomesModule primaryOutcomes measure: The effect of the different scanning techniques on the scanning quality and time, secondaryOutcomes measure: The effect of the bracket presence on the scanning quality, eligibilityModule sex: ALL, minimumAge: 14 Years, maximumAge: 35 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Faculty of Dentistry, Cairo university, city: Cairo, country: Egypt, geoPoint lat: 30.06263, lon: 31.24967, hasResults: False
protocolSection identificationModule nctId: NCT06340841, orgStudyIdInfo id: LEMURS SSI 24, briefTitle: LEMURS SSI: Evaluation of Behavioral Incentives, acronym: LEMURSSI, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-12, primaryCompletionDateStruct date: 2024-05-31, completionDateStruct date: 2028-05-31, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: University of Vermont, class: OTHER, descriptionModule briefSummary: The goal of this substudy is to determine if a brief single-session-intervention (SSI) coupled with different incentive strategies to support engaging in wellness-related activities., conditionsModule conditions: Incentives, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: FACTORIAL, interventionModelDescription: Participants will be randomized to one of four incentive conditions and receive rewards based on their completion of such activities. There are two main factors (Recipient x Restoration) that will create four distinct groups., primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule interventions name: Personal Incentives, interventions name: Personal Restorative Incentives, interventions name: Charity Incentives, interventions name: Charity Restorative Incentives, outcomesModule primaryOutcomes measure: Activity Completion, secondaryOutcomes measure: Depression, Anxiety, Stress Scale - 21, secondaryOutcomes measure: Depression, Anxiety, Stress Scale - 21, secondaryOutcomes measure: Depression, Anxiety, Stress Scale - 21, secondaryOutcomes measure: Warwick-Edinburgh Mental Well-being Scale, secondaryOutcomes measure: Oura Ring Sleep Index, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 20 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Vermont, status: RECRUITING, city: Burlington, state: Vermont, zip: 05405, country: United States, contacts name: Matthew Price, PhD, role: CONTACT, phone: 802-656-9196, email: Matthew.Price@uvm.edu, geoPoint lat: 44.47588, lon: -73.21207, hasResults: False
protocolSection identificationModule nctId: NCT06340828, orgStudyIdInfo id: 2023-KY-186-01, briefTitle: Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-20, primaryCompletionDateStruct date: 2027-07-20, completionDateStruct date: 2027-07-20, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-03, sponsorCollaboratorsModule leadSponsor name: The Second Hospital of Nanjing Medical University, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to learn about effectiveness and safety of washing microbiota transplantation in diabetic gastrointestinal motility disorders participant population. The main questions it aims to answer are:* The risk factors of diabetic gastrointestinal motility disorders in routine clinical data or biochemical tests.* The composition of gut microbiota in diabetic gastrointestinal motility disorders patients and potential pathogenic bacteria.* The efficacy of washing microbiota transplantation in the clinical treatment of diabetic gastrointestinal motility disorders patients and potential factors that may influence treatment outcomes.* The potential mechanisms of washing microbiota transplantation in treating diabetic gastrointestinal motility disorders patients.Participants will be collected fasting venous blood and random stool samples before treatment and at week 12 post-treatment, conducting scale assessments before treatment and at weeks 1, 4, and 12 post-treatment., conditionsModule conditions: Diabetic Gastroparesis, conditions: Diabetic Gastropathy, conditions: Diabetic Gastroenteropathy, conditions: Diabetic Gastroparesis Associated With Type 2 Diabetes Mellitus, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Washing Microbiota Transplantation, outcomesModule primaryOutcomes measure: Gastrointestinal Symptom Rating Scale, primaryOutcomes measure: Gut Microbiome Sequencing, secondaryOutcomes measure: Gastroparesis Cardinal Symptom Index, secondaryOutcomes measure: Composite Autonomic Symptom Score 31, secondaryOutcomes measure: Gastrointestinal Motility, secondaryOutcomes measure: Heart Rate Variability, secondaryOutcomes measure: Serum Metabolites, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: The Second Affiliated Hospital of Nanjing Medical University, city: Nanjing, state: Jiangsu, zip: 210000, country: China, contacts name: Dafa Ding, Professor, role: CONTACT, phone: +8615850514014, email: dingdafa@njmu.edu.cn, geoPoint lat: 32.06167, lon: 118.77778, hasResults: False